Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Viridian Therapeutics Ors Shs (VRDN)  
$13.90 0.01 (0.07%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 62,717,000
Market Cap: 871.77(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.12 - $27.87
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 17.7
Insider 3/6 Months : 18.3
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Viridian Therapeutics is a biotechnology company. Co. has built relevant capabilities in monoclonal antibody discovery and engineering, biologics manufacturing, and nonclinical and clinical development for thyroid eye disease (TED) and other undisclosed target indications. Co. is developing two product candidates, VRDN-001 and VRDN-002, to treat patients who suffer from TED. Co.'s key program, VRDN-001, is a humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) for the treatment for TED. VRDN-002, a distinct IGF-1R antibody is designed to support administration as a convenient, low volume, subcutaneous injection to treat patients who suffer from TED.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 476,190 476,190 911,221
Total Buy Value $0 $9,999,990 $9,999,990 $20,261,772
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 1 4
Total Shares Sold 0 0 7,500 306,218
Total Sell Value $0 $0 $186,137 $9,690,089
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 3 19
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 118
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Katz Barrett Chief Medical Officer   •       –      –    2023-01-09 4 AS $33.04 $417,064 D/D (12,623) 0 -32%     
   Katz Barrett Chief Medical Officer   •       –      –    2023-01-09 4 OE $23.03 $290,708 D/D 12,623 12,623     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-21 4 AS $29.19 $476,556 D/D (16,326) 0 -6%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-21 4 OE $23.03 $375,988 D/D 16,326 16,326     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-20 4 AS $28.07 $16,842 D/D (600) 0 1%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-20 4 OE $23.03 $13,818 D/D 600 600     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-16 4 AS $28.44 $36,887 D/D (1,297) 0 1%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-16 4 OE $23.03 $29,870 D/D 1,297 1,297     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-15 4 AS $28.08 $8,424 D/D (300) 0 1%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-15 4 OE $23.03 $6,909 D/D 300 300     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-14 4 AS $28.12 $440,247 D/D (15,656) 0 -1%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-14 4 OE $23.03 $360,558 D/D 15,656 15,656     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-12 4 AS $28.05 $16,830 D/D (600) 0 9%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-12-12 4 OE $23.03 $13,818 D/D 600 600     -
   Meisner Lara General Counsel and Secretary   •       –      –    2022-11-15 4 AS $22.05 $179,156 D/D (8,125) 0 12%     
   Meisner Lara General Counsel and Secretary   •       –      –    2022-11-15 4 OE $14.00 $113,750 D/D 8,125 8,125     -
   Fairmount Healthcare Fund Ii L.p. Director   –       •       •   2022-08-17 4 B $23.50 $9,999,979 I/I 425,531 1,363,764 2.25 24%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-06-01 4 AS $12.20 $366,000 D/D (30,000) 480,905 63%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-05-02 4 AS $13.04 $391,200 D/D (30,000) 510,905 73%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-04-04 4 AS $18.93 $68,148 D/D (3,600) 540,905 -22%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-04-01 4 AS $18.92 $499,488 D/D (26,400) 544,505 -27%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-03-02 4 AS $17.36 $192,800 D/D (11,106) 570,905 -27%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-03-01 4 AS $17.82 $336,691 D/D (18,894) 582,011 -30%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-02-03 4 AS $19.16 $17,416 D/D (909) 600,905 -46%     
   Violin Jonathan Chief Executive Officer   •       •      –    2022-02-02 4 AS $18.47 $227,920 D/D (12,340) 601,814 -41%     
  118 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us